Xilio Therapeutics Inc (XLO)
1.02
-0.03
(-2.86%)
USD |
NASDAQ |
Jun 14, 16:00
1.02
0.00 (0.00%)
Pre-Market: 09:25
Xilio Therapeutics 1 Year Total Returns (Daily): -60.00% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
June 14, 2024 | -60.00% |
June 13, 2024 | -59.30% |
June 12, 2024 | -62.14% |
June 11, 2024 | -60.84% |
June 10, 2024 | -62.94% |
June 07, 2024 | -62.63% |
June 06, 2024 | -66.17% |
June 05, 2024 | -66.94% |
June 04, 2024 | -63.76% |
June 03, 2024 | -64.77% |
May 31, 2024 | -64.59% |
May 30, 2024 | -69.50% |
May 29, 2024 | -69.41% |
May 28, 2024 | -70.02% |
May 24, 2024 | -66.88% |
May 23, 2024 | -64.92% |
May 22, 2024 | -63.49% |
May 21, 2024 | -62.38% |
May 20, 2024 | -60.82% |
May 17, 2024 | -63.58% |
May 16, 2024 | -65.61% |
May 15, 2024 | -63.52% |
May 14, 2024 | -65.62% |
May 13, 2024 | -64.67% |
May 10, 2024 | -63.12% |
Date | Value |
---|---|
May 09, 2024 | -60.62% |
May 08, 2024 | -61.38% |
May 07, 2024 | -59.62% |
May 06, 2024 | -59.94% |
May 03, 2024 | -61.69% |
May 02, 2024 | -67.08% |
May 01, 2024 | -65.38% |
April 30, 2024 | -68.48% |
April 29, 2024 | -68.48% |
April 26, 2024 | -66.04% |
April 25, 2024 | -68.83% |
April 24, 2024 | -66.35% |
April 23, 2024 | -67.29% |
April 22, 2024 | -65.73% |
April 19, 2024 | -63.26% |
April 18, 2024 | -59.62% |
April 17, 2024 | -62.15% |
April 16, 2024 | -60.61% |
April 15, 2024 | -61.82% |
April 12, 2024 | -65.29% |
April 11, 2024 | -60.64% |
April 10, 2024 | -59.37% |
April 09, 2024 | -59.57% |
April 08, 2024 | -54.63% |
April 05, 2024 | -60.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.33%
Minimum
Nov 09 2022
42.79%
Maximum
Jun 20 2023
-48.10%
Average
-62.14%
Median
Jun 12 2024
1 Year Total Returns (Daily) Benchmarks
Gilead Sciences Inc | -13.05% |
FibroGen Inc | -93.17% |
Avalo Therapeutics Inc | -98.50% |
IGM Biosciences Inc | -27.05% |
AEON Biopharma Inc | -87.02% |